IRadimed
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1025 Willa Springs Dr, Winter Springs, F...Phone Number
(407) 677-8022Website
www.iradimed.comRevenue
$86.3 MillionStock Symbol
IRMDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About IRadimed
iRadimed Corporation is a leader in the development of innovative magnetic resonance imaging (MRI) compatible medical devices. We are the only known provider of a non-magnetic intravenous (IV) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependRead more
IRadimed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IRadimed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if IRadimed has recently received funding, and reach out quickly before it becomes old news!
Click to see if IRadimed had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if IRadimed is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on IRadimed recently announced quarterly report
Product Launch: Get notified when IRadimed launches new products
Funding: Get notified immidiatlly once IRadimed has new funding data
IRadimed, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at IRadimed
Recommended Actions
Reach out to Masked Content who joined IRadimed as Masked Content
Find 3 more new buyers
Compare Similar Companies to IRadimed
Compare insights from companies similar to IRadimed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IRadimed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IRadimed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IRadimed.
IRadimed financials insights
Gather financial insights about IRadimed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$12.6M
IRadimed Tech Stack
A closer look at the technologies used by IRadimed
Most Recent Scoops
Project
Person-Based
Person-Based
Person-Based
Person-Based
IRadimed News & Media
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report
Iradimed Corp (NASDAQ:IRMD) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. The stock has returned nearly 80% over the past year, and analysts see more upside potential in it. Iradimed reported its Q1 2026 results on May 1, and the results marked a strong start […]IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and New Product Demand
iRadimed Corp (IRMD) reports a 13% revenue increase and robust demand for its new MR IV pump system, despite production challenges.IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call May 1, 2026 11:00 AM EDTCompany ParticipantsRoger Susi - Founder, Chairman, CEO & PresidentJohn Glenn...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IRadimed
Sign Up For FreeTo access detailed company insights
iRadimed Corporation is a leader in the development of innovative magnetic resonance imaging (MRI) compatible medical devices. We are the only known provider of a non-magnetic intravenous (IV) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that la... Read More
